• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于体内肿瘤生长动力学的正态性:数据库分析

On the normality of growth dynamics of neoplasms in vivo: a data base analysis.

作者信息

Skehan P

出版信息

Growth. 1986 Winter;50(4):496-515.

PMID:3596327
Abstract

The in vivo population dynamics of 248 literature data bases of normal and neoplastic growth processes were examined by computer velocity analysis. The growth of most tumors was remarkably normal. When abnormalities did occur, they tended to be infrequent and subtle. Tumor growth was highly regulated, not unregulated Exponential growth was rare, and the kinetics of both normal tissues and tumors were predominantly deceleratory. With both normal tissues and tumors, the most intense period of growth inhibition usually occurred early in development. In general, growth was rapid only at small size. There was no evidence that tumors as a group grew faster than normal tissues. A small subclass of tumors exhibited a specific proliferative abnormality. Their growth did not stop entirely at large size, but instead continued indefinitely at a very slow basal rate. The majority of tumors did not exhibit this anomaly, however. Eight of the data bases permitted a kinetic analysis of the inhibitory mechanisms underlying growth inhibition. Six behaved as if their growth were governed by a tissue sizer, that is, by a negative feedback inhibition that strongly correlated with tumor size. The seventh behaved as if its growth were regulated by a biological time-keeper, and the final tumor as if by a stochastic mechanism such as random arrest or terminal differentiation. The analysis indicated that many tumors were completely normal in their growth governance policies and control mechanisms, and suggested that in some instances neoplastic transformation might be a disease of tissue neogenesis resulting from an altered or inappropriate cellular recognition process. The ability of 18 different equations to model in vivo growth data was examined. Accurate modeling required an equation to be objectively selected from a menu of alternatives by statistical criteria. All but one of the equations provided a best-fit to at least one data base, and all of the equations were inferior models of some data bases. The Spillman and inverse Nth root equations provided the greatest number of best-fits. The Gompertz equation was a good growth model for normal tissues, but mediocre for tumors.

摘要

通过计算机速度分析研究了248个正常和肿瘤生长过程文献数据库的体内种群动态。大多数肿瘤的生长明显正常。当确实出现异常时,往往不常见且不明显。肿瘤生长受到高度调节,并非不受调节。指数生长很少见,正常组织和肿瘤的动力学主要是减速的。对于正常组织和肿瘤,生长抑制最强烈的时期通常发生在发育早期。一般来说,只有在体积较小时生长才迅速。没有证据表明肿瘤作为一个整体比正常组织生长得更快。一小类肿瘤表现出特定的增殖异常。它们的生长在体积较大时不会完全停止,而是以非常缓慢的基础速率无限期持续。然而,大多数肿瘤并未表现出这种异常。其中8个数据库允许对生长抑制背后的抑制机制进行动力学分析。6个表现得好像其生长受组织大小调节器控制,也就是说,受与肿瘤大小密切相关的负反馈抑制控制。第7个表现得好像其生长受生物钟调节,最后一个肿瘤则好像受随机机制如随机停滞或终末分化调节。分析表明,许多肿瘤在其生长调控策略和控制机制方面完全正常,并表明在某些情况下,肿瘤转化可能是由于细胞识别过程改变或不适当而导致的组织新生疾病。研究了18种不同方程对体内生长数据的建模能力。准确建模需要根据统计标准从一系列备选方程中客观地选择一个方程。除了一个方程外,所有方程都至少对一个数据库提供了最佳拟合,并且所有方程对某些数据库来说都是较差的模型。斯皮尔曼方程和倒数第N次方根方程提供的最佳拟合数量最多。冈珀茨方程是正常组织的良好生长模型,但对肿瘤来说则一般。

相似文献

1
On the normality of growth dynamics of neoplasms in vivo: a data base analysis.关于体内肿瘤生长动力学的正态性:数据库分析
Growth. 1986 Winter;50(4):496-515.
2
Deceleratory growth by a rat glial tumor line in culture.
Cancer Res. 1982 May;42(5):1636-40.
3
Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.关于:罗森塔尔·迪、格拉茨坦·埃。《我们有了一种治疗方法,但疾病是什么?》,《肿瘤学家》1996年;第1期。
Oncologist. 1997;2(1):59-61.
4
Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.胚胎团块以及妊娠相关激素对四种小鼠肿瘤生长差异的影响。
Oncol Res. 2002;13(3):147-60.
5
A single-cell-based model of tumor growth in vitro: monolayers and spheroids.一种基于单细胞的体外肿瘤生长模型:单层培养物和球体。
Phys Biol. 2005 Jul 12;2(3):133-47. doi: 10.1088/1478-3975/2/3/001.
6
Information dynamics in carcinogenesis and tumor growth.致癌作用和肿瘤生长中的信息动力学
Mutat Res. 2004 Dec 21;568(2):259-73. doi: 10.1016/j.mrfmmm.2004.04.018.
7
[Kinetics of breast neoplasms].[乳腺肿瘤的动力学]
Minerva Med. 1994 Jan-Feb;85(1-2):7-16.
8
Mathematical modeling of human embryonic and fetal growth rates.
Growth Dev Aging. 1999 Spring-Summer;63(1-2):49-59.
9
NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).NTP对甲基丁香酚(CAS编号93-15-2)在F344/N大鼠和B6C3F1小鼠中的毒理学及致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 2000 Jul;491:1-412.
10
Computer simulation of cell growth governed by stochastic processes: application to clonal growth cancer models.由随机过程控制的细胞生长的计算机模拟:在克隆生长癌症模型中的应用。
Toxicol Appl Pharmacol. 1994 Feb;124(2):284-95. doi: 10.1006/taap.1994.1034.

引用本文的文献

1
Investigation of solid tumor progression with account of proliferation/migration dichotomy via Darwinian mathematical model.通过达尔文数学模型研究实体瘤的增殖/迁移二分法与进展。
J Math Biol. 2020 Feb;80(3):601-626. doi: 10.1007/s00285-019-01434-4. Epub 2019 Oct 1.
2
Lifespan based pharmacokinetic-pharmacodynamic model of tumor growth inhibition by anticancer therapeutics.基于寿命的抗癌治疗药物抑制肿瘤生长的药代动力学-药效学模型。
PLoS One. 2014 Oct 21;9(10):e109747. doi: 10.1371/journal.pone.0109747. eCollection 2014.
3
Using Fractal Geometry and Universal Growth Curves as Diagnostics for Comparing Tumor Vasculature and Metabolic Rate With Healthy Tissue and for Predicting Responses to Drug Therapies.
利用分形几何和通用生长曲线进行诊断,以比较肿瘤血管和代谢率与健康组织的差异,并预测对药物治疗的反应。
Discrete Continuous Dyn Syst Ser B. 2013 Jun;18(4). doi: 10.3934/dcdsb.2013.18.1077.
4
A quantitative theory of solid tumor growth, metabolic rate and vascularization.实体瘤生长、代谢率和血管生成的定量理论。
PLoS One. 2011;6(9):e22973. doi: 10.1371/journal.pone.0022973. Epub 2011 Sep 29.
5
Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity.基于增殖活性定量差异化学敏感性的标准化动力学微量测定法。
J Cancer Res Clin Oncol. 1992;118(1):35-43. doi: 10.1007/BF01192309.